Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
NCT01958775
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
GLP-2
DRUG:
Placebo
Sponsor
University Health Network, Toronto